Core Insights - The pharmaceutical manufacturing industry in China is experiencing significant growth, with a notable increase in export value projected for 2025 [1][2]. Industry Overview - The export value of China's pharmaceutical manufacturing industry reached 19.42 billion yuan in August 2025, marking a year-on-year growth of 16.2% [1]. - Cumulatively, from January to August 2025, the total export value amounted to 153.68 billion yuan, reflecting a year-on-year increase of 11.6% [1]. Related Companies - Key listed companies in the pharmaceutical sector include: - China National Pharmaceutical Modern (国药现代, 600420) - Kunming Pharmaceutical Group (昆药集团, 600422) - Pien Tze Huang (片仔癀, 600436) - Qianjin Pharmaceutical (千金药业, 600479) - Tianjin Pharmaceutical (津药药业, 600488) - China National Pharmaceutical (国药股份, 600511) - Lianhuan Pharmaceutical (联环药业, 600513) - HeFu China (合富中国, 603122) - Kanghui Pharmaceutical (康惠制药, 603139) - Shapuaisi (莎普爱思, 603168) - Aoxiang Pharmaceutical (奥翔药业, 603229) - Dazhenlin (大参林, 603233) [1].
2025年1-8月全国医药制造业出口货值为1536.8亿元，累计增长11.6%
Chan Ye Xin Xi Wang·2025-10-05 01:59